Blog

Jan Clark: I am delighted and honoured to have being selected as a 2024 IASLC Patient Advocate Educational Award winner

Photo taken from Jan Clark/LinkedIn

May 29, 2024, 06:00

Jan Clark: I am delighted and honoured to have being selected as a 2024 IASLC Patient Advocate Educational Award winner

Oncogene Cancer Research shared a post by Jan Clark, Diagnostic Oncology National Sales Manager at BD, on LinkedIn, adding the following:

“Thrilled that our Co-founder and Secretary Jan Clark has been selected as an IASLC Patient Advocate Educational Award winner. Educating and supporting patient advocates is key to improving lung cancer outcomes. Thank you International Association for the Study of Lung Cancer.”

Quoting Jan Clark’s post:

“I am delighted and honoured to have being selected as a 2024 IASLC Patient Advocate Educational Award winner.”

2024 award winner BD cancer cancer research advocacy IASLC Patient Advocate Educational Award improving cancer outcomes International Association for the Study of Lung Cancer Jan Clark lung cancer education lung cancer outcomes OncoDaily Oncogene Cancer Research Oncology Patient Advocacy patient support

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage